Skip to main content
Erschienen in: Intensive Care Medicine 4/2020

08.01.2020 | Understanding the Disease

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin

verfasst von: J. J. Rouby, C. Sole-Lleonart, J. Rello, the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia

Erschienen in: Intensive Care Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

The use of nebulized antibiotics for treating ventilator-associated pneumonia (VAP) caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB) increases worldwide. There is a paradox, however, between the large body of experimental evidence supporting the administration of nebulized rather than intravenous aminoglycosides and colistin to treat inoculation pneumonia caused by GNB [1, 2], and the paucity of clinical studies confirming such a benefit in VAP. Based on the recommendations of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) [3, 4], the present article examines this apparent contradiction and suggests some directions for further research and clinical practice. …
Literatur
1.
Zurück zum Zitat Rouby JJ, Bouhemad B, Monsel A et al (2012) Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies. Anesthesiology 117:1364–1380CrossRef Rouby JJ, Bouhemad B, Monsel A et al (2012) Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies. Anesthesiology 117:1364–1380CrossRef
2.
Zurück zum Zitat Dhanani JA, Diab S, Chaudhary J et al (2019) Lung pharmacokinetics of tobramycin by intravenous and nebulized dosing in a mechanically ventilated healthy ovine model. Anesthesiology 131:344–355CrossRef Dhanani JA, Diab S, Chaudhary J et al (2019) Lung pharmacokinetics of tobramycin by intravenous and nebulized dosing in a mechanically ventilated healthy ovine model. Anesthesiology 131:344–355CrossRef
3.
Zurück zum Zitat Rello J, Rouby JJ, Sole-Lleonart C et al (2017) Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients. Clin Microbiol Infect 23:640–646CrossRef Rello J, Rouby JJ, Sole-Lleonart C et al (2017) Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients. Clin Microbiol Infect 23:640–646CrossRef
4.
Zurück zum Zitat Rello J, Solé-Lleonart C, Rouby JJ et al (2017) Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 23:629–639CrossRef Rello J, Solé-Lleonart C, Rouby JJ et al (2017) Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 23:629–639CrossRef
5.
Zurück zum Zitat Rouby JJ, Monsel A (2019) Nebulized antibiotics: epithelial lining fluid concentrations overestimate lung tissue concentrations. Anesthesiology 131:229–322CrossRef Rouby JJ, Monsel A (2019) Nebulized antibiotics: epithelial lining fluid concentrations overestimate lung tissue concentrations. Anesthesiology 131:229–322CrossRef
6.
Zurück zum Zitat Elman M, Goldstein I, Marquette CH, Wallet F, Lenaour G, Rouby JJ (2002) Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 97:199–206CrossRef Elman M, Goldstein I, Marquette CH, Wallet F, Lenaour G, Rouby JJ (2002) Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 97:199–206CrossRef
7.
Zurück zum Zitat Lu Q, Girardi C, Zhang M et al (2010) Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 36:1147–1155CrossRef Lu Q, Girardi C, Zhang M et al (2010) Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 36:1147–1155CrossRef
8.
Zurück zum Zitat Athanassa ZE, Markantonis SL, Fousteri MZ et al (2012) Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients. Intensive Care Med 38:1779–1786CrossRef Athanassa ZE, Markantonis SL, Fousteri MZ et al (2012) Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients. Intensive Care Med 38:1779–1786CrossRef
9.
Zurück zum Zitat Boisson M, Jacobs M, Grégoire N et al (2014) Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. Antimicob Agents Chemother 58:7331–7339CrossRef Boisson M, Jacobs M, Grégoire N et al (2014) Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. Antimicob Agents Chemother 58:7331–7339CrossRef
10.
Zurück zum Zitat Solé-Lleonart C, Rouby JJ, Blot S et al (2017) Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anesthesiology 126:890–908CrossRef Solé-Lleonart C, Rouby JJ, Blot S et al (2017) Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anesthesiology 126:890–908CrossRef
11.
Zurück zum Zitat Leone M, Bouadma L, Bouhemad B et al (2018) Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med 37:83–98CrossRef Leone M, Bouadma L, Bouhemad B et al (2018) Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med 37:83–98CrossRef
12.
Zurück zum Zitat Kollef MH, Ricard JD, Roux D et al (2017) A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: aFIS trial. Chest 151:1239–1246CrossRef Kollef MH, Ricard JD, Roux D et al (2017) A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: aFIS trial. Chest 151:1239–1246CrossRef
13.
Zurück zum Zitat Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ, the Nebulized Antibiotics Study Group (2011) Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 184:106–115CrossRef Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, Rouby JJ, the Nebulized Antibiotics Study Group (2011) Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 184:106–115CrossRef
14.
Zurück zum Zitat Dugernier J, Reychler G, Wittebole X et al (2016) Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care 6(1):73CrossRef Dugernier J, Reychler G, Wittebole X et al (2016) Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care 6(1):73CrossRef
15.
Zurück zum Zitat Mashat M, Clark BJ, Assi KH, Chrystyn H (2016) In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems. Pulm Pharmacol Ther 37:37e42CrossRef Mashat M, Clark BJ, Assi KH, Chrystyn H (2016) In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems. Pulm Pharmacol Ther 37:37e42CrossRef
17.
Zurück zum Zitat Galindo-Filho VC, Alcoforado L, Rattes C et al (2019) A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: a randomized controlled trial with radiolabeled aerosols. Respir Med 153:60–67CrossRef Galindo-Filho VC, Alcoforado L, Rattes C et al (2019) A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: a randomized controlled trial with radiolabeled aerosols. Respir Med 153:60–67CrossRef
18.
Zurück zum Zitat Dunne RB, Shortt S (2018) Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med 36:641–646CrossRef Dunne RB, Shortt S (2018) Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med 36:641–646CrossRef
Metadaten
Titel
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
verfasst von
J. J. Rouby
C. Sole-Lleonart
J. Rello
the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia
Publikationsdatum
08.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 4/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05890-w

Weitere Artikel der Ausgabe 4/2020

Intensive Care Medicine 4/2020 Zur Ausgabe

Tipps für den Umgang mit Behandlungsfehlern

01.05.2024 DGIM 2024 Kongressbericht

Es ist nur eine Frage der Zeit, bis es zu einem Zwischenfall kommt und ein Behandlungsfehler passiert. Doch wenn Ärztinnen und Ärzte gut vorbereitet sind, schaffen es alle Beteiligten den Umständen entsprechend gut durch diese Krise. 

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.